Skip to main content
Equibles

TSP Capital Management Group, LLC

Position in NVAX — Novavax Inc

CIK 1317208 Summit, NJ
Back to NVAX Full portfolio

Position in NVAX

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$13,370,418
+$2,051,217 QoQ
Shares Held
1,419,365
+2.1% QoQ
Ownership
0.861%
of shares outstanding
% of Portfolio
3.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TSP Capital Management Group, LLC holds $44,103,648 across 3 Biotechnology names. NVAX ranks #3 (30.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MNKD
Mannkind Corp
 3,972,675 $16,923,595
2 CLDX
Celldex Therapeutics, Inc.
 371,127 $13,809,635
3 NVAX
Novavax Inc
This page 		1,419,365 $13,370,418

All Filings in NVAX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,370,418 1,419,365
2026-03-31 $11,319,201 1,390,565
2025-12-31 $9,334,517 1,389,065
2025-09-30 $12,129,893 1,399,065
2025-06-30 $8,814,112 1,399,065
2025-03-31 $8,667,377 1,352,165
2024-12-31 $10,922,862 1,358,565
2024-09-30 $17,061,424 1,350,865
2024-06-30 $17,434,402 1,377,125
2024-03-31 $6,581,821 1,376,950
2023-12-31 $5,336,160 1,111,700
2023-09-30 $6,996,374 966,350
2023-06-30 $2,732,382 367,750
2023-03-31 $1,647,607 237,750
2022-12-31 $164,737 16,025
2022-09-30 $292,000 16,025
2022-06-30 $824,000 16,025
2022-03-31 $1,180,000 16,025
2021-12-31 $2,364,000 16,525
2021-09-30 $3,840,000 18,525
2021-06-30 $3,933,000 18,525
2021-03-31 $4,265,317 23,525
2020-12-31 $5,583,863 50,075
2020-09-30 $6,509,000 60,075
2020-06-30 $6,049,000 72,575
2020-03-31 $1,905,000 140,250